• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

      Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

      CRISPR Combined with Glowing Proteins for Viral Detection

      CRISPR Combined with Glowing Proteins for Viral Detection

      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

    • Radiology
      Imaging Technique Reveals Contraction Patterns During Labor

      Imaging Technique Reveals Contraction Patterns During Labor

      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

      Ultrasound Catheter to Treat Hypertension

      Ultrasound Catheter to Treat Hypertension

      Antibacterial Smart Sutures Visible in CT Scans

      Antibacterial Smart Sutures Visible in CT Scans

    • Cardiology
      Scientists Grow Electrodes Inside The Body

      Scientists Grow Electrodes Inside The Body

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Tiny Patch for Cardiac Ultrasound Imaging

      Tiny Patch for Cardiac Ultrasound Imaging

      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

    • Surgery
      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Self-Assembling Peptides as a Bioink

      Self-Assembling Peptides as a Bioink

      3D Bioengineered Skin Grafts Fit Complex Anatomy

      3D Bioengineered Skin Grafts Fit Complex Anatomy

    • Nanomedicine
      Bottlebrush Particle for Synergistic Drug Combinations

      Bottlebrush Particle for Synergistic Drug Combinations

      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

      Improved Membrane Coating for Anti-Cancer Nanoparticles

      Improved Membrane Coating for Anti-Cancer Nanoparticles

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Non-Surgical Solution for Fecal Incontinence: Interview with Miles Rosen, CEO of Pelvalon

April 21st, 2021 Conn Hastings Exclusive, GI, Ob/Gyn

Fecal incontinence can be extremely challenging for those who suffer it. The condition can be embarrassing, making it difficult for people to tell others or even their doctor about it, and it is more common than you might think. Fecal incontinence can affect anyone, but a key group of patients includes women during menopause, in whom it is often associated with previous pelvic trauma, such as that which occurs during child-birth.

Treatment options are relatively limited and either tend to be minimalist, such as lifestyle changes, or pretty intense, such as expensive surgical implants. There was a gap for a low-risk and low-cost treatment that could still achieve impressive efficacy. This is the niche that Pelvalon, a medtech company based in Santa Clara, California, hopes to fill.

Pelvalon’s Eclipse system is conceived as a minimally invasive solution to fecal incontinence in women. It consists of a vaginal insert that can be inflated to control the nearby rectum, where gentle pressure from the inflated insert obstructs the passage of stool. When the user needs to use the restroom, the insert can easily be deflated for that purpose.

Medgadget had the opportunity to speak with Miles Rosen, founder and CEO at Pelvalon, about the technology.       

Conn Hastings, Medgadget: Please give us an overview of fecal incontinence, and the consequences it can have for patients.

Miles Rosen, Pelvalon: Just like loss of bladder control, loss of bowel control is a pelvic floor disorder, in which symptoms often begin around the age of menopause and can trace back to child delivery or other past trauma to the pelvic region. Nerve or muscle damage in the pelvic region can affect bowel control, as can diarrhea, Irritable Bowel Syndrome or other gastrointestinal conditions. It can be embarrassing, even devastating in the wrong circumstances. Women who lose control of their bowels often feel like they have lost control of their life.

Medgadget: How common is fecal incontinence? It is rare for people to talk about it, so most are likely unaware when someone is suffering from the condition.

Miles Rosen: Since many people don’t talk about loss of bowel control, it’s more common than you might think. It affects 10-15% of women, with the average age of onset being 47 to 55. Accidents can happen on a monthly or more frequent basis. Many women report fearing a simple trip to work or the grocery store, not being able to exercise, and missing out on valuable time with friends and family. Unfortunately, many women don’t bring it up with their doctor due to embarrassment and a belief that there are not good treatment options out there.

Medgadget: How is the condition currently treated, and what are the limitations with these approaches?

Miles Rosen: Typical first-line treatments include dietary changes, exercise and medications. Until now, there really weren’t any conservative treatments that had been proven effective short of invasive surgical implants. The most widely covered therapy is a surgical device that costs over $30,000 to implant. Physicians have commented that lower risk treatments are desperately needed, as there is a large gap in the treatment algorithm.

Medgadget: Please give us an overview of the Eclipse System and how it works.

Miles Rosen: A non-surgical vaginal insert, Eclipse is placed in a similar position as a tampon and has been cleared by the Food and Drug Administration (FDA) to treat loss of bowel control. The insert contains no hormones or drugs, and can be inserted or removed at any time. A well-fit insert will be comfortable for almost all women. In fact, 96% of women who were successfully fit with the insert and completed a clinical study found it to be comfortable and either could not feel it or reported that if they could feel it, it was comfortable.

A detachable and discreet pump is used to inflate and deflate a balloon on the insert. The balloon is designed to control the rectum and prevent stool from passing before a trip to the bathroom. After a bowel movement, the balloon can be inflated again. This design allows women to actively control their bowels, while keeping the insert in place throughout the day.

Medgadget: How was the system conceived?

Miles Rosen: When I started working in the space, I was shocked to learn that fecal incontinence affects so many young, active women. Through the course of clinical trials, I’ve spoken to over a hundred patients about their condition. It strips women of having control over their lives, forcing them to give up careers, social engagements, and exercise. The uncertainty and fear associated with their loss of bowel control can be debilitating and isolating.

In talking with physicians, they would tell me that they didn’t have great solutions to offer patients, especially less invasive treatment ones. To fill this need, we worked with gynecologists to develop a new, non-surgical option for women that’s as easy to use and just as comfortable as other commonly-used female products. The technology originated from Stanford University’s Byers Center for Biodesign, a health technology innovation training program.

Medgadget: What are the advantages of the system compared with other solutions for fecal incontinence?

Miles Rosen: Eclipse has a huge advantage when it comes to the risk and cost profile. As I mentioned earlier, the only effective treatment to date is a surgical implant placed near the spine that costs over $30,000 to implant, plus ongoing annual costs. As a non-surgical vaginal insert, Eclipse can easily be removed at any time and has a dramatically different risk profile. In 10 years of clinical testing, there has never been a serious adverse event associated with the device.

Another advantage of the insert is that it is familiar to women and providers. Vaginal inserts have been used for decades with other conditions so it’s something providers and patients are used to. The user acceptance has been affirmed in the clinical data, with 96% of patients reporting that the insert was comfortable. 

Additionally, Eclipse is quick and effective. Patients can leave the office continent on day one whereas with other treatments, the mechanism of action kicks in over time. Multiple clinical studies have shown the device to be over 80% effective, which is high in any disease state, but especially fecal incontinence, which has notoriously been difficult to treat.

The largest barrier for us has been reimbursement. Due to Eclipse being new type of device, it didn’t have an appropriate code and payment. With that now in place, it will significantly improve access to the technology. It will also provide cost savings to payers, as it is significantly cheaper and less invasive than the alternative treatments. Eclipse has already made a huge difference in the lives of the patients who have used it and we look forward to bringing this solution to more clinicians across the country.

Product info page: Eclipse system…

Flashbacks: Pelvalon’s Eclipse Vaginal Insert for Fecal Incontinence FDA Approved; Second Generation Eclipse System for Fecal Incontinence FDA Cleared

Conn Hastings

Conn Hastings received a PhD from the Royal College of Surgeons in Ireland for his work in drug delivery, investigating the potential of injectable hydrogels to deliver cells, drugs and nanoparticles in the treatment of cancer and cardiovascular diseases. After achieving his PhD and completing a year of postdoctoral research, Conn pursued a career in academic publishing, before becoming a full-time science writer and editor, combining his experience within the biomedical sciences with his passion for written communication.

Sponsored
Venture builder BHV Partners launches Conus Airway to improve anaesthesia  and respiratory surgery

Venture builder BHV Partners launches Conus Airway to improve anaesthesia and respiratory surgery

FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

interviews & reviews
Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Imagene Profiles Cancer Biomarkers in Real Time

Imagene Profiles Cancer Biomarkers in Real Time

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
Posting....
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email